Fig. 1

The intratumor heterogeneity score of BRCA cases. (A) The intratumor heterogeneity score of each BRCA patients. (C) High intratumor heterogeneity score indicated a poor overall survival rate in BRCA. (D) The different expressed genes between in high and low intratumor heterogeneity score group. (E) Univariate cox analysis identified potential prognostic biomarkers in BRCA.